Statera Biopharma Inc. Made Headway

Wed, Nov 29, 2023 at 07:45 PM

Statera Biopharma Inc. (STAB:NASDAQ) rocketted at $0, a gain of 50%. On Wed, Nov 29, 2023, STAB:NASDAQ hit a New 2-Week High of $0. From Thu, Nov 16, 2023, the stock recorded 0.00% Up Days and 0.00% Green Days

About Statera Biopharma Inc. (STAB:NASDAQ)

Statera BioPharma Inc is a clinical-stage biopharmaceutical company addressing autoimmune and inflammatory diseases, blood disorders, infectious diseases, and cancer.

Top 10 Gainers:

Vivos Therapeutics Inc. (VVOS:NASDAQ), 831.82%
Unico American Corporation (UNAM:NASDAQ), 354.55%
Altamira Therapeutics Ltd. (CYTO:NASDAQ), 180.22%
PROOF Acquisition Corp I Class A (PACI:NYSE), 148.32%
Yoshiharu Global Co. (YOSH:NASDAQ), 93.11%
Conduit Pharmaceuticals Inc Com (CDT:NASDAQ), 72.88%
Republic First Bancorp, Inc. (FRBK:NASDAQ), 65.19%
Envoy Med Inc Cl A (COCH:NASDAQ), 55.93%
vTv Therapeutics Inc. (VTVT:NASDAQ), 55.87%
Statera Biopharma Inc. (STAB:NASDAQ), 50%